Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop

Core Insights - Curium has expanded its partnership with Institute of Isotopes Co. Ltd. to provide Iodine-131 diagnostic capsules in the Nordic Region and other European countries by late 2025, with regulatory approvals underway [1][2] - The expansion follows Curium's investment in increasing I-131 production capacity at its Petten facility in the Netherlands, which includes adding a manufacturing shift and investing in automation and a new bulk production line [1][2] Company Overview - Curium is a leading company in nuclear medicine, developing, manufacturing, and distributing radiopharmaceutical products globally, serving over 14 million patients annually [3] - The company emphasizes innovation and excellence in its operations, honoring the legacy of Marie and Pierre Curie [3] Partner Overview - Institute of Isotopes Co. Ltd. specializes in radioisotope technology and has developed a range of products for nuclear medicine, focusing on supplying radiopharmaceuticals for patient recovery and early diagnosis [4] - The collaboration with Curium enhances the availability of I-131 products essential for thyroid treatments across several European countries [2][4]